{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 45, "transaction_limit": 160, "filters": {"q": "", "ticker": "INCY", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 45, "acquisition_count": 29, "disposal_count": 16, "acquisition_value": 57473.52, "acquisition_value_label": "$57.5K", "disposal_value": 10496539.24, "disposal_value_label": "$10.5M", "net_value": -10439065.72, "net_value_label": "$-10.4M", "flow_tone": "negative", "largest_value_label": "$3.2M", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 45, "value": "10554012.7600", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$10.6M"}], "days": [{"transaction_date": "2026-06-30", "acquisitions": 3, "disposals": 0, "total": 3, "bar_width": 10.7}, {"transaction_date": "2026-07-02", "acquisitions": 0, "disposals": 4, "total": 4, "bar_width": 14.3}, {"transaction_date": "2026-07-14", "acquisitions": 0, "disposals": 4, "total": 4, "bar_width": 14.3}, {"transaction_date": "2026-07-15", "acquisitions": 0, "disposals": 6, "total": 6, "bar_width": 21.4}, {"transaction_date": "2026-07-16", "acquisitions": 26, "disposals": 2, "total": 28, "bar_width": 100.0}], "side_mix": {"acquisitions": 29, "disposals": 16, "acquisition_share": 64.4, "disposal_share": 35.6}}, "company_flows": [{"symbol": "INCY", "name": "Incyte Corporation", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "acquisitions": 29, "disposals": 16, "acquired_value": 57473.52, "acquired_value_label": "$57.5K", "disposed_value": 10496539.24, "disposed_value_label": "$10.5M", "net_value": -10439065.72, "net_value_label": "$-10.4M", "acquisition_share": 64.4, "disposal_share": 35.6, "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}], "company_overview": [{"symbol": "INCY", "name": "Incyte Corporation", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "filings": 45, "acquisitions": 29, "disposals": 16, "acquired_value": 57473.52, "acquired_value_label": "$57.5K", "disposed_value": 10496539.24, "disposed_value_label": "$10.5M", "net_value": -10439065.72, "net_value_label": "$-10.4M", "acquisition_share": 64.4, "disposal_share": 35.6, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}], "transactions": [{"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1877.0, "share_price": 114.73, "transaction_value": 215348.21, "fetched_at": "2026-07-30T11:11:16.523528+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1093.0, "share_price": 115.01, "transaction_value": 125705.93, "fetched_at": "2026-07-30T11:11:16.501022+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 12479.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.510407+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4991.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.508967+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 21548.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.512105+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 57861.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.499395+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 33508.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.497626+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13403.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.495991+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GARDNER, DAVID H", "executive_title": "EVP, Chief Strategy Officer", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 18487.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.515148+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GARDNER, DAVID H", "executive_title": "EVP, Chief Strategy Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 31923.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.516874+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GARDNER, DAVID H", "executive_title": "EVP, Chief Strategy Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7395.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.513615+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HOFFMAN, RICHARD A.", "executive_title": "EVP & General Counsel", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 31923.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.528398+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HOFFMAN, RICHARD A.", "executive_title": "EVP & General Counsel", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7395.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.519091+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HOFFMAN, RICHARD A.", "executive_title": "EVP & General Counsel", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 18487.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.521611+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7857.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.503188+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 33918.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.507486+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 19643.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.505343+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 25538.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.494470+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 14790.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.492507+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5916.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.490479+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 80421.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.532155+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 26807.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.529914+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 77148.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.533642+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 9798.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.481592+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 42298.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.488905+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 24496.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.487088+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2834.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.526538+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 4079.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.525108+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 28237.0, "share_price": 113.05, "transaction_value": 3192192.85, "fetched_at": "2026-07-30T11:11:16.540822+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4950.0, "share_price": 115.09, "transaction_value": 569695.5, "fetched_at": "2026-07-30T11:11:16.537012+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3088.0, "share_price": 115.09, "transaction_value": 355397.92, "fetched_at": "2026-07-30T11:11:16.542251+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1512.0, "share_price": 115.09, "transaction_value": 174016.08, "fetched_at": "2026-07-30T11:11:16.538511+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1099.0, "share_price": 115.09, "transaction_value": 126483.91, "fetched_at": "2026-07-30T11:11:16.543854+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1098.0, "share_price": 115.09, "transaction_value": 126368.82, "fetched_at": "2026-07-30T11:11:16.535432+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 21830.0, "share_price": 114.88, "transaction_value": 2507830.4, "fetched_at": "2026-07-30T11:11:16.550432+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 17969.0, "share_price": 114.88, "transaction_value": 2064278.72, "fetched_at": "2026-07-30T11:11:16.548638+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 692.0, "share_price": 114.88, "transaction_value": 79496.96, "fetched_at": "2026-07-30T11:11:16.545600+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 437.0, "share_price": 114.88, "transaction_value": 50202.56, "fetched_at": "2026-07-30T11:11:16.547193+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer, President", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4779.0, "share_price": 116.86, "transaction_value": 558473.94, "fetched_at": "2026-07-23T11:07:13.955193+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2177.0, "share_price": 116.86, "transaction_value": 254404.22, "fetched_at": "2026-07-23T11:07:13.953433+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 477.0, "share_price": 116.86, "transaction_value": 55742.22, "fetched_at": "2026-07-23T11:07:13.950372+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 350.0, "share_price": 116.86, "transaction_value": 40901.0, "fetched_at": "2026-07-23T11:07:13.951916+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "HARRIGAN, EDMUND", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 255.0, "share_price": 113.36, "transaction_value": 28906.8, "fetched_at": "2026-07-21T21:56:36.138914+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "CLANCY, PAUL J", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 252.0, "share_price": 113.36, "transaction_value": 28566.72, "fetched_at": "2026-07-21T21:56:36.141816+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BAKER, BROS. ADVISORS LP", "executive_title": "Director, 10% Owner", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 400.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:56:36.140299+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}